US 11642398
Factor IX polypeptide formulations
granted A61KA61K38/4846A61K47/02
Quick answer
US patent 11642398 (Factor IX polypeptide formulations) held by BIOVERATIV THERAPEUTICS INC. expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K38/4846, A61K47/02, A61K47/10, A61K47/22